!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Baylor College of Medicine

Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management (PLATINUM) (H-47150)

Description

Content

In this study, we are enrolling patients who present to our Emergency Center who have a high blood potassium level (hyperkalemia). The goal of this study is to evaluate if patiromer can help lower potassium levels while patients are in the emergency department. Patiromer is a drug that is already FDA approved.  This is a phase 4 randomized, double-blinded, placebo-controlled parallel group study.

Learn more information.

Contact

EM Research Team

Phone 1: 713–873–9818

IRB: H-47150

Status:

Active

Created:

Back to topback-to-top